Skip to main content

Table 1 Baseline clinical characteristics of study population according to left ventricular remodeling status at follow up (left ventricular hypertrophy vs. non-left ventricular hypertrophy, left ventricular enlargement vs. non-left ventricular enlargement)

From: Incidence and predictors of left ventricular remodeling among elderly Asian women: a community-based cohort study

Characteristic

All subjects (n = 474)

Groups

P-value

Groups

P-value

LVH (n = 49)

Non-LVH (n = 425)

LVE (n = 55)

Non-LVE (n = 419)

Age (years)

71.85±6.47

72.39±6.54

71.80±6.49

0.148

72.88±6.27

71.74±6.48

0.046

BMI (kg/m2)

24.35±3.18

27.08±3.47

24.03±2.98

0.000

26.95±3.72

24.00±2.93

0.000

SBP (mmHg)

138.85±20.50

151.02±19.61

137.39±20.12

0.000

150.25±20.80

137.37±20.01

0.000

DBP (mmHg)

76.49±11.20

81.67±9.15

75.79±11.14

0.000

81.82±10.35

75.80±11.44

0.000

CBP (mmHg)

144.35±22.30

157.13±21.28

142.93±19.80

0.000

157.05±24.34

142.70±21.51

0.000

baPWV (cm/s)

16.32 (14.42, 18.67)

17.47 (14.93, 20.53)

15.21 (13.98, 18.44)

0.000

17.10 (15.13, 19.73)

16.21 (14.31, 17.98)

0.028

Hypertension

205 (43.2%)

29 (59.2%)

176 (41.4%)

0.022

31 (56.4%)

174 (41.5%)

0.058

Diabetes

48 (10.1%)

6 (12.2%)

42 (9.9%)

0.514

7 (12.7%)

41 (9.8%)

0.281

Dyslipidemia

121 (25.2%)

13 (26.5%)

108 (25.4%)

0.865

18 (32.7%)

103 (24.6%)

0.237

Laboratory tests

TC (mmol/l)

5.31±0.96

5.37±1.06

5.30±0.95

0.820

5.30±1.07

5.31±0.95

0.964

TG (mmol/l)

1.77±0.39

1.82±0.23

1.77±0.41

0.750

1.87±0.64

1.76±0.58

0.479

HDL-C (mmol/l)

1.32±0.32

1.31±0.35

1.32±0.31

0.802

1.27±0.29

1.32±0.32

0.212

LDL-C (mmol/l)

3.28±0.75

3.24±0.63

3.28±0.56

0.758

3.72±0.70

3.22±0.83

0.015

FPG (mmol/l)

5.39±1.01

5.59±0.78

5.37±0.96

0.249

5.53±0.66

5.37±0.41

0.337

HbA1C (%)

5.98±0.98

5.92±0.56

5.99±1.01

0.553

6.08±0.54

5.88±0.79

0.169

BNP (pg/ml)

60.0 (35.0, 95.0)

75.0 (40.0, 133.0)

60.0 (35.0, 91.5)

0.016

70.0 (42.0, 123.0)

60.0 (35.0, 93.5)

0.254

HCY (umol/l)

11.0 (9.5, 14.0)

12.0 (10.0,14.0)

11.0 (9.0, 14.0)

0.354

11.0 (9.0, 14.0)

11.0 (9.0, 13.5)

0.750

hsCRP (mg/l)

1.35 (0.69, 2.59)

1.98 (0.99, 3.27)

1.31 (0.68, 2.51)

0.019

1.97 (0.99, 3.86)

1.30 (0.67, 2.34)

0.004

UA (umol/l)

310.0 (263.5, 361.5)

323.0 (286.0, 346.0)

309.0 (263.0, 363.0)

0.207

308.0 (268.0, 365.0)

310.0 (264.0, 361.0)

0.745

  1. Continuous variables with normal distribution were expressed as the mean±SD. In case of skewed distribution continuous variables (containing baPWV, BNP, HCY, hsCRP, UA) were presented as median (inter-quartile range)
  2. BMI body mass index, BNP B-type natriuretic peptide, DBP diastolic blood pressure, FPG fasting plasma glucose, LVH left ventricular hypertrophy, LVE left ventricular enlargement, HCY homocysteine, HDL-C high-density lipoprotein cholesterol, hsCRP high-sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, SBP systolic blood pressure, TC total cholesterol, TG total triglycerides
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us